Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Reavill

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
Neuropharmacology|August 8, 2001
SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxietyM D Wood, C Reavill, B Trail, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 25, 2000
Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resourceP M Nolan, J Peters, L Vizor, et al.
Journal of Medicinal Chemistry|May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the ratG Stemp, T Ashmeade, C L Branch, et al.
Molecular and Cellular Neurosciences|December 31, 2003
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric diseaseS M Harrison, C Reavill, G Brown, et al.
Molecular and Cellular Neurosciences|June 21, 2001
Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient miceH M Prosser, C H Gill, W D Hirst, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-AC Reavill, S G Taylor, M D Wood, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
Neuropharmacology|August 8, 2001
SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxietyM D Wood, C Reavill, B Trail, et al.
Mammalian Genome : Official Journal of the International Mammalian Genome Society|July 25, 2000
Implementation of a large-scale ENU mutagenesis program: towards increasing the mouse mutant resourceP M Nolan, J Peters, L Vizor, et al.
Journal of Medicinal Chemistry|May 5, 2000
Design and synthesis of trans-N-[4-[2-(6-cyano-1,2,3, 4-tetrahydroisoquinolin-2-yl)ethyl]cyclohexyl]-4-quinolinecarboxamide (SB-277011): A potent and selective dopamine D(3) receptor antagonist with high oral bioavailability and CNS penetration in the ratG Stemp, T Ashmeade, C L Branch, et al.
Molecular and Cellular Neurosciences|December 31, 2003
LPA1 receptor-deficient mice have phenotypic changes observed in psychiatric diseaseS M Harrison, C Reavill, G Brown, et al.
Molecular and Cellular Neurosciences|June 21, 2001
Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient miceH M Prosser, C H Gill, W D Hirst, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 17, 2000
Pharmacological actions of a novel, high-affinity, and selective human dopamine D(3) receptor antagonist, SB-277011-AC Reavill, S G Taylor, M D Wood, et al.
Pageof 5